Rheumatic
Fever in Utah, 1998: When a
sore throat isnt just a sore throat...
Whats going on? The Bureau of
Epidemiology was recently contacted by physicians at Primary Childrens Medical
Center (PCMC) and the University of Utah School of Medicine regarding an increase in the
number of rheumatic fever cases being diagnosed, and an increase in the detection of
isolates of a specific group A streptococcal (GAS) strain that has been associated with an
increased risk of rheumatic fever. This situation has prompted a closer look at rheumatic
fever in Utah.While still a major health problem
worldwide, rheumatic fever had nearly disappeared in the United States by the early 1970s.
In 1983 there were only 88 reported cases in this country, compared to more than 10,000 in
1961. The reasons for the disappearance are uncertain, but improved living conditions,
access to medical care, and the availability of antimicrobials that are effective against
GAS infections, are all believed to be at least partially responsible.
After several decades of a decline in cases of acute
rheumatic fever in Utah, an unusual increase was noted in early 1985. By the end of 1987,
two Salt Lake City hospitals had reported 150 new cases. The incidence of rheumatic fever
in Utah declined from the end of 1987 until 1997, but remained higher than the nationally
reported incidence (Veasy LG, Tani LY, Hill HR. J.Pediatr 1994; 124:9-16). Beginning in
1997, another unusual increase in the number of cases of rheumatic fever was noted.
Forty-two children with rheumatic fever were evaluated at PCMC in 1997, and since the
beginning of 1998, more than 30 children with rheumatic fever have been seen.
These unusual increases in Utahs rheumatic fever
incidence have been temporally associated with the isolation of specific GAS strains from
the community. An increase in throat culture isolates of two mucoid GAS strains, M type 18
and M type 3, was observed in Utah children from 1985 to mid-1987. Similar strains were
rarely identified in the laboratory at PCMC from mid-1987 to 1996; however, from 1997 to
the present, mucoid strains of GAS are again being regularly identified. Twenty-three
cultures of mucoid GAS collected during 1997 and 1998 were sent to Dr. Edward Kaplan,
director of the World Health Streptococcal Reference Laboratory in Minneapolis, Minnesota.
Twenty-one of the 23 heavily encapsulated strains were M type 18. [For more detailed
information about the 1985-1987 resurgence see: Veasy LG, Wiedmeier SE, Orsmond GS et al.
Resurgence of acute rheumatic fever in the intermountain area of the United States. NEJM
1987; 316: 8, 421-427; and, CDC. Acute Rheumatic Fever -- Utah. MMWR 1987; 36:
108-110, 115.}
Please note a change in reporting of rheumatic fever to
the Utah Department of Health! Prior to January 1998, cases of rheumatic fever were
reported to the Bureau of Chronic Disease Control. They should now be reported to the
Bureau of Epidemiology. To expedite the reporting of a suspected case of rheumatic fever,
the primary physician or the consulting physician may report the case by telephone
to (801)538-6191. (Please do not hesitate to report because you think someone else has
already reported the case! If a case is reported twice, we will identify the duplication.)
We ask that physicians or other health care providers contact the Bureau of Epidemiology
as soon as possible when a new case of rheumatic fever is identified. Investigators will
then contact the patients health care provider and promote appropriate follow-up
care of the patient and their household contacts. For a case to be counted as a confirmed
case of rheumatic fever, it must meet the criteria set by the Centers for Disease Control
and Prevention (see below). To expedite the case investigation process, please include the
criteria used for the diagnosis of rheumatic fever in your report.
What is necessary to diagnose rheumatic fever? The
clinical description of rheumatic fever is an inflammatory illness that occurs as a
delayed sequela of GAS upper respiratory infection. The case definition for rheumatic
fever is as follows:
Major Criteria for diagnosis: carditis,
polyarthritis, chorea, subcutaneous nodules, and erythema marginatum;
Minor Criteria for diagnosis: a) previous rheumatic
fever or rheumatic heart disease; b)arthralgia; c) fever; d) elevated erythrocyte
sedimentation rate, positive C-reactive protein, or leukocytosis; and e) prolonged PR
interval on an electrocardiogram.
A case of rheumatic fever is confirmed when there is an
illness characterized by two major criteria or one major and two minor criteria (as
described in the clinical description), and by supporting evidence of preceding GAS
infection. [Comments: Supporting evidence to confirm streptococcal infection includes
increased anti-streptolysin-O or other streptococcal antibodies, throat culture positive
for GAS, or recent scarlet fever. The absence of supporting evidence of preceding
streptococcal infection should make the diagnosis doubtful, except in Sydenham chorea or
low-grade carditis when rheumatic fever is first discovered after a long latent period
from the antecedent infection. There is no one specific laboratory test for the diagnosis
of rheumatic fever.] (Reference: CDC. Case definitions for infectious conditions under
public health surveillance. MMWR 1997; 46 (No. RR-10):52-53.)
What should be done with a suspected case of rheumatic
fever that does not meet the case definition? We are interested in knowing about these
suspected cases even if they do not meet the case definition. Please report them to the
Bureau of Epidemiology.
What can be done to prevent rheumatic fever? The
proper diagnosis and treatment of GAS upper respiratory infections can prevent cases of
rheumatic fever from occurring. When a child is diagnosed with rheumatic fever, the
1997 Red Book (Report of the American Academy of Pediatrics Committee on Infectious
Diseases, 24th edition) instructs clinicians to obtain throat cultures from all of their
siblings and any other household contacts. Any household contact with a positive culture
should be treated with an appropriate course of antibiotics, regardless of whether they
are or have recently been symptomatic.
The 1997 Red Book also reminds clinicians that
"the throat culture remains the test of choice" for children who are suspected
of having GAS pharyngitis (p. 486). Clinical diagnoses are rarely appropriate for a strep
throat because it is difficult to accurately distinguish viral from streptococcal
pharyngitis. A number of rapid diagnostic tests for GAS pharyngitis (rapid strep tests)
are available. However, these vary in their sensitivity. If a rapid strep test produces a
negative result, a throat culture should be obtained to make sure the patient does not
have GAS pharyngitis. The specificity of rapid strep tests is high, however, and a
positive test need not be followed by a throat culture.
The key to successful treatment of GAS pharyngitis is the
completion of an appropriate course of antibiotics. Penicillin remains the drug of choice
(except in penicillin-allergic individuals), but alternate antibiotics may be prescribed.
An appropriate course of antibiotics is also recommended for household contacts of
rheumatic fever patients but this may or may not be sufficient to eliminate streptococcal
carriage. The table below lists alternate regimens for the treatment of GAS pharyngitis.
| Regimen |
Dose/duration |
| Penicillin V |
250 mg 2-3 times/day PO for 10
days (children) OR 500 mg 2-3 times/day PO for 10 days (adolescents or adults) |
| Erythromycin estolate |
20-40 mg/kg/day in 2-4 divided
doses PO for 10 days |
| Erythromycin ethyl succinate |
40 mg/kg/day in 2-4 divided doses
PO for 10 days |
| Benzathine penicillin |
600,000 U for pts <27 kg (60
lb) as single IM injection OR 1,200,000 U for pts >27 kg (60 lb) as single IM
injection |
| Cefpodoxime proxetil |
10 mg/kg/day 2 times/day PO for 5
days |
| Azithromycin |
12 mg/kg/day once a day PO for 5
days |
| Cefadroxil * |
30 mg/kg/day 2 times/day PO for 5
days |
| Cefuroxime axetil * |
20 mg/kg/day 2 times/day PO for
4-5 days |
*These short course regimens are still pending FDA
approval.[For more information about the proper diagnosis and treatment of GAS pharyngitis
and rheumatic fever, refer to the 1997 Red Book, pages 483-494. Short course
regimens for GAS pharyngitis are also described in Dajani AS. Current Therapy of Group A
Streptococcal Pharyngitis. Pediatric Annals 1998; 27(5): 277-280.
Return
Caution: Ticks
Ahead Report on Selected
Vector-borne Diseases Utah 1990-1997
With the recent wet weather, the ground
cover will be thick and green making it a good home for ticks. Health care providers
should be on the lookout for vector-borne diseases and make sure their patients are tested
appropriately. The following is a brief description of the vector-borne diseases found in
Utah and their prevalence.
The most commonly reported vector-borne disease in Utah is Colorado
Tick Fever (CTF). The Colorado Tick Fever virus causes the disease. The virus is
maintained in a wild rodent reservoir and is transmitted to humans by the bite of the
Rocky Mountain wood tick (Dermacentor andersoni). CTF is endemic to Western U.S.
and Canada at elevations above 5,000 feet. For the eight-year period, 1990-1997, there
were 93 reported cases of CTF in Utah residents (Table 1). The highest number of cases,
twenty-three, occurred in 1993; while the lowest, four, was reported in 1996. The county
of residence with the highest cumulative incidence (per 100,000) was Wasatch County
(27.43) followed by Summit (6.94). Sixty-one percent of the cases were male. Ages of cases
ranged from one to 90 years of age, with the mean age being 35.7 years of age (Male: 1-90
years, mean 38.7 years, Female: 3-76 years, mean 30.5 years).
Twenty-three cases of tularemia were reported in Utah for
1990-1997 (Table 1). One of these cases died. Of the cases, 87% were male. Ages of the
patients ranged from two to 75 years of age with the median age being 38.2 years. Seven of
the cases had an unknown exposure. Of those cases with known exposure, five were
associated with deer fly bites, four because of a cat bite or scratch, three from contact
with rabbits or rabbit pelts, and one from a tick bite.
Tularemia, also known as rabbit fever, can be transmitted through many
different routes, including handling infected rabbits or other animals, ingestion of
undercooked, infected meat, and by tick or deer fly bites. The incubation period for
tularemia is about three days, with a range of two to ten days. Symptoms generally include
chills, fever, malaise, and often enlarged glands. The presentation of this disease varies
with the means by which it is acquired: ingestion of infected meat may cause pharyngitis
and gastrointestinal symptoms; exposure through handling the meat may cause an ulcer on
the hand; inhalation of infectious material causes pneumonia. Diagnosis is generally made
through fourfold rise or greater in antibody titer between acute and convalescent serum
specimens or by isolation of Francisella tularensis from ulcer exudate, lymph node
aspirate or blood.
Utah has had four cases of plague reported during 1990 to 1997
(Table 1). The first three cases presented with bubonic plague. Bubonic plague is marked
by a high fever and the characteristic bubo, or swollen lymph node, usually inguinal,
sometimes axillary or cervical. There was no source confirmed for any of these cases. The
1994 case was a pneumonic plague case that was acquired from a cat. Pneumonic plague may
occur as the result of secondary spread of Yersinia pestis to the lung. Primary
pneumonic plague occurs as a result of inhalation of droplets expelled by an animal or
human with plague pneumonia. The third form of plague is the septicemic form.
The reservoir for Yersinia pestis is wild rodents in the Western
U.S. Transmission usually occurs by flea bite, though it can be transmitted through
handling infected tissues of rodents or in the case of pneumonic plague, through the
respiratory route. Diagnosis of plague is confirmed by culture and identification of the
organism from aspirate of the bubo, from blood, or by four fold rise/fall in antibody
titer. Plague is reportable immediately by telephone. Public health follow-up of cases
includes identification of the source so that appropriate intervention can be made to
prevent other cases. Prevention measures include avoidance of prairie dog towns, not
handling or eating rodents, especially sick animals, and keeping domestic animals free of
fleas.
Relapsing fever or Borrelia recurrentis (Borrelia spp.)
is an uncommon illness characterized by fever episodes lasting from 3 to 6 days followed
by an afebrile period of about a week. Relapses become progressively shorter and milder as
the afebrile period becomes longer. A fleeting macular rash on the trunk frequently
occurs. In the Western U.S. the disease is carried by a soft-bodied tick (Ornithodoros
species). In the last eight years, five cases have been reported in Utah residents (Table
1).
Six cases of Rocky Mountain spotted fever (RMSF) were reported
in Utah residents during the eight year period (Table 1). The disease is much more common
in the south central and eastern states. Only one of the cases was known to be acquired
outside of Utah. RMSF is the most serious of the tick-borne diseases.
Seventeen cases of Lyme disease have been reported in Utah
residents between 1990 and 1997 (Table 1). Seventy-one percent of the cases were female
and ages of the cases ranged from 2 to 68 years with a median age of 35 years. Seven cases
(41%) were acquired outside of the state. The surveillance case definition used to report
Lyme disease is either the presence of erythema migrans, the characteristic lesion
associated with this disease, at least 5 mm in diameter; or positive serology and one of
the late manifestations associated with this illness: neurologic, cardiac, or arthritic
abnormalities. The incubation period for Lyme disease ranges from 3 to 32 days. Beginning
symptoms include the characteristic erythema migrans, malaise, fatigue, fever, headache,
stiff neck, myalgia, migratory arthralgias, or lymphadenopathy. Tick studies show that Ixodes
pacificus is present in Utah, but no Borrelia burgdorferi was found in any tick
or mouse studies.
The last vector-borne reportable disease to be discussed is malaria.
Utah has had 30 cases of malaria reported over the past eight years (Table 1). All of the
cases have been imported from outside the United States. Over one third (11) of the cases
were imported from Africa, another third were imported from India (6) and Central America
(6). The remaining third were imported from Indonesia (3), Philippines (1), Pakistan (1),
and one with a travel history that includes several Caribbean Islands and Central America.
Twenty (70%) of the cases have been male. Almost 50% of the cases were between 20 and 29
years of age.
Malaria is a parasitic disease caused by one or more of the following
sporozoan parasites: Plasmodium vivax, P. malariae, P. falciparum and
P. ovale. The disease is transmitted by the bite of the female Anopheles
mosquito. The incubation period or time between the infective bite and the appearance of
clinical symptoms is approximately 7-14 days for P. falciparum, 8-14 for P. vivax
and P. ovale and 7-30 days for P. malariae. To prevent malaria, all
travelers to the subtropics and tropics should check with their local health department or
physician for information on malarial prophylaxis.
The State Public Health Laboratory or the Centers for Disease Control
and Prevention (CDC) can test for these diseases. Physicians may call 584-8400 for further
information about specimen collection and submission. Single copies of fact sheets on
vector-borne diseases are available from the Bureau of Epidemiology, 538-6191.
| Table 1. Cases of Vector-borne Diseases, Utah 1990-1997 |
| Disease |
1990 |
1991 |
1992 |
1993 |
1994 |
1995 |
1996 |
1997 |
Total |
| Colorado Tick Fever |
12 |
16 |
14 |
23 |
7 |
11 |
4 |
6 |
93 |
| Lyme Disease |
1 |
2 |
6 |
2 |
3 |
1 |
1 |
1 |
17 |
| Malaria |
0 |
5 |
5 |
2 |
4 |
6 |
5 |
3 |
30 |
| Plague |
0 |
1 |
1 |
1 |
1 |
0 |
0 |
0 |
4 |
| Relapsing Fever |
1 |
0 |
1 |
0 |
0 |
0 |
2 |
1 |
5 |
| Rocky Mountain Spotted Fever |
3 |
0 |
1 |
0 |
0 |
1 |
0 |
1 |
6 |
| Tularemia |
4 |
6 |
2 |
2 |
2 |
0 |
3 |
4 |
23 |
Return
|